Navigation Links
Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects
Date:8/2/2008

Houston-based Law Firm Offers Assistance, Information to People Affected by Dangerous Tysabri Effects.

Houston, TX (PRWEB) August 2, 2008 -- Tysabri side effects lawyers Pulaski & Middleman announce the launch of a http://www.tysabrilawsuitattorney.com [website] dedicated to assisting people who are suffering serious side effects as a result of taking Tysabri (natalizumab).

Tysabri, a drug used to treat multiple sclerosis (MS) and Crohn's disease, is marketed by Irish drug company Elan and US biotechnology firm Biogen Idec.

In 2005, Tysabri was briefly pulled out of the market after three patients participating in clinical trials contracted progressive multifocal leukoencephalopathy (PML), a rare but deadly viral brain infection. Although the drug was eventually re-released, two more cases of PML were reported in mid-2008, raising more concerns about Tysabri's safety and side effects.

The U.S. Food and Drug Administration (FDA) has also warned that Tysabri has the potential to cause serious liver damage leading to death or the need for a liver transplant.

As experienced litigators, http://www.tysabrilawsuitattorney.com [Tysabri lawyers] Pulaski & Middleman stand ready to assist people who have been adversely affected by this potentially dangerous drug.

About Pulaski & Middleman:
A Houston-based law firm, Pulaski & Middleman has successfully resolved thousands of cases and helped countless clients during its 15-year history. They pride themselves in a personal approach to even the most complicated cases, including medical malpractice, product liability, and other areas of personal injury law.

If you or someone you love is suffering from the side effects of Tysabri, contact Pulaski & Middleman at http://www.tysabrilawsuitattorney.com and discuss your case with a Tysabri attorney today.

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1171064.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stopping Tysabri May Worsen MS
2. MS Drug Tysabri Approved for Crohns Disease
3. Tysabri May Cause Liver Damage, Health Officials Say
4. Connecticut Trial Lawyers Ask Doctors to Question Insurers Excess Profits
5. Marin County Scandal and Elder Abuse Horror: Lawsuits Link Death Nurse, Bay Area lawyers, Doctor and Blind Eye by Local, State, and National Public Officials
6. Granholm Looks To Make Big Bucks for Personal Injury Lawyers, Says Michigan Chamber of Commerce
7. Darwin Introduces Enhancements to its Lawyers Professional Liability Insurance Policy Including Privacy Wrongful Acts and More
8. The Case for Trial Lawyers
9. Get Your Fruits & Veggies: CDC
10. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
11. Story ideas from molecular & cellular proteomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & ... (TGIG), has initiated cultivation and processing operations at its production facility, and opened ... , Puradigm is the manufacturer of a complete system of proactive air and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology: